Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
190M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
19.3M
-
Shares change
-
+3.61M
-
Total reported value, excl. options
-
$359M
-
Value change
-
+$67M
-
Number of buys
-
42
-
Number of sells
-
-10
-
Price
-
$18.60
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q2 2017
58 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q2 2017.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.3M shares
of 190M outstanding shares and own 10.17% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (7.09M shares), Redmile Group, LLC (2.22M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.76M shares), FMR LLC (1.63M shares), Foresite Capital Management III, LLC (1M shares), DEERFIELD MANAGEMENT CO (747K shares), PERCEPTIVE ADVISORS LLC (663K shares), New Leaf Venture Partners, L.L.C. (658K shares), BlackRock Inc. (548K shares), and EVENTIDE ASSET MANAGEMENT, LLC (434K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.